Platelet-rich plasma
Autologous PRP options are considered for appropriate wounds as part of a documented wound-bed and tissue-repair strategy.
The RegenWound Protocol brings PRP, BPC-157/TB-500 peptide review, advanced biologics, ultrasound-assisted therapies, and physician-directed regenerative support into the same practice that can manage bedside care, clinic procedures, tele-wound, and surgical escalation.
When a wound stalls, the answer should not be a blind referral to another group. Capital Wound evaluates the wound, chooses the right escalation layer, and keeps the same clinical team responsible through closure.
Autologous PRP options are considered for appropriate wounds as part of a documented wound-bed and tissue-repair strategy.
BPC-157, TB-500, and other physician-directed peptide protocols are reviewed case by case, with eligibility, sourcing, safety, and compliance handled before any treatment decision.
Ultrasound therapies may support wound-bed preparation, debridement planning, and the timing of biologic or procedural escalation.
Advanced biologic products and graft-adjacent treatments are selected around wound type, vascular supply, infection status, and documentation requirements.
Some advanced wound-care procedures may be covered by Medicare, Medicaid, or commercial plans when medical-necessity and documentation criteria are met. Coverage varies by diagnosis, product, plan, and prior authorization requirements. Inquire before scheduling so the team can review eligibility.
The RegenWound Protocol is a marketable care package built around evaluation, wound-bed preparation, regenerative treatment selection, tele-wound follow-up, and surgical escalation when needed.
Assess perfusion, infection risk, depth, drainage, prior therapies, and the reason the wound has stalled.
Select PRP, advanced biologics, ultrasound therapies, or physician-directed regenerative peptide support when clinically appropriate.
Tele-wound check-ins, clinic procedures, and OR escalation remain connected to the same team, so there is no risk of losing the patient to an outside provider.
Advanced wound-care procedures are positioned inside the larger limb-preservation continuum: treat infection earlier, reduce avoidable amputation risk, and escalate before a salvageable limb is lost.
Regenerative care is paired with debridement, biologics, structural correction, and OR access when a limb is still salvageable.
Earlier escalation, coordinated follow-up, and surgical access help prevent wounds from drifting into emergency infection pathways.
The same clinical team owns the case from first assessment through advanced treatment, surgical escalation, and closure.
Send the diagnosis, wound location, duration, prior therapies, and current insurance. We will review whether an advanced wound-care pathway makes sense.